ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

MLTX MoonLake Immunotherapeutics

45.26
2.69 (6.32%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
MoonLake Immunotherapeutics MLTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
2.69 6.32% 45.26 09:00:00
개장가 저가 고가 종가 전일 종가
43.51 43.405 45.465 45.26 42.57
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
10/04/202420:00BWMoonLake Immunotherapeutics Inks Three-Year Technology..
11/03/202421:01EDGAR2Form 8-K - Current report
11/03/202401:00GLOBEMoonLake announces significant improvements with Nanobody®..
04/03/202422:00GLOBEMoonLake Immunotherapeutics to present MIRA trial data of..
01/03/202409:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202409:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202422:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/02/202422:03EDGAR2Form 8-K - Current report
29/02/202422:00GLOBEMoonLake Immunotherapeutics Reports Full Year 2023 Financial..
26/02/202423:00EDGAR2Form 8-K - Current report
26/02/202422:00GLOBEMoonLake Immunotherapeutics Announces Positive Feedback from..
24/02/202406:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202408:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202408:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202408:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202406:02EDGAR2Form 144 - Report of proposed sale of securities
15/02/202422:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:05EDGAR2Form 144 - Report of proposed sale of securities
22/12/202306:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202306:16EDGAR2Form 144 - Report of proposed sale of securities
20/12/202306:34EDGAR2Form 144 - Report of proposed sale of securities
14/11/202322:00GLOBEMoonLake Immunotherapeutics Reports Third Quarter 2023..
06/11/202321:55EDGAR2Form 8-K - Current report
06/11/202301:00GLOBEMoonLake Immunotherapeutics announces landmark Phase 2..
16/10/202319:16EDGAR2Form 8-K - Current report
15/10/202322:03GLOBEMoonLake Immunotherapeutics announces the full dataset from..
11/10/202323:15GLOBEMoonLake Immunotherapeutics presents positive 12-week data..
04/10/202320:01GLOBEPhase 2 MIRA primary analysis trial results (12-week) for..
06/09/202320:00GLOBEMoonLake Immunotherapeutics to host a Capital Markets Day on..
10/08/202320:00GLOBEMoonLake Immunotherapeutics Reports Second Quarter 2023..
25/07/202321:00GLOBEMoonLake completes patient randomization ahead of schedule..
17/07/202320:30IHMARKETNEWSMonday’s Wall Street Highlights: Microsoft, Santander,..
28/06/202318:00GLOBEMoonLake Immunotherapeutics Announces Pricing of $400..
27/06/202305:01GLOBEMoonLake Immunotherapeutics Announces Proposed Underwritten..
25/06/202322:00GLOBEMoonLake Immunotherapeutics achieves landmark milestone with..
12/05/202320:45GLOBEMoonLake Immunotherapeutics Reports First Quarter 2023..

최근 히스토리

Delayed Upgrade Clock